D.E. Shaw & Co
HLTH

D.E. Shaw & Co’s Cue Health Inc. Common Stock HLTH Stock Holding History

D.E. Shaw & Co’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-476,733
Closed -$77.5K – 4848
2023
Q4 		$77.5K Sell
476,733
-193,684
-29% -$64.3K ﹤0.01% 3994
2023
Q3 		$297K Sell
670,417
-74,322
-10% -$33.9K ﹤0.01% 3620
2023
Q2 		$275K Buy
744,739
+350,604
+89% +$299K ﹤0.01% 3630
2023
Q1 		$717K Sell
394,135
-30,543
-7% -$66.4K ﹤0.01% 3371
2022
Q4 		$879K Sell
424,678
-100,248
-19% -$317K ﹤0.01% 3536
2022
Q3 		$1.58M Sell
524,926
-123,630
-19% -$438K ﹤0.01% 3212
2022
Q2 		$2.08M Buy
648,556
+598,549
+1,197% +$3.24M ﹤0.01% 3037
2022
Q1 		$323K Buy
50,007
+28,370
+131% +$257K ﹤0.01% 4614
2021
Q4 		$290K Buy
+21,637
New +$238K ﹤0.01% 4694

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $860M AUM 17.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co's HLTH Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Cue Health Inc. Common Stock (HLTH) in Q1 2024, closing a stake of 476,733 shares — an estimated $77.5K sold.

D.E. Shaw & Co first reported a position in HLTH in Q4 2021 and held it in 9 quarters. The position peaked at $2.08M in Q2 2022. 57 funds tracked by Wall St. Rank hold HLTH as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Cue Health Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 476,733 Cue Health Inc. Common Stock shares in Q1 2024, an estimated $77.5K.
  • D.E. Shaw & Co first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • D.E. Shaw & Co's Cue Health Inc. Common Stock position peaked at $2.08M in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.